Overview

Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab

Status:
Unknown status

Trial end date:
2020-01-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the one-year visual outcome and prognostic factors after intraocular injections of ranibizumab under pro re nata treatment regimen for the patients with diabetic macular edema (DME).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Sun Yat-sen University

Treatments:

Ranibizumab